NAMS
NewAmsterdam Pharma Company N.V.
$27.05
+$0.36(+1.35%)
50
Overall
--
Value
50
Tech
--
Quality
Market Cap
$2.76B
Volume
711.97K
52W Range
$14.06 - $27.35
Target Price
$41.50
Key Metrics Overview
| Market Cap | $2.76B | P/E Ratio | N/A |
| 52W High | $27.35 | 52W Low | $14.06 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | -63.3% | 52W Position | 97.7% |
| Overall Score | 50 | Value Score | -- |
| Quality Score | -- | Technical Score | 50 |
Growth Analysis
| EPS Current Est | $-1.47 | EPS Next Est | $-2.06 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NAMS | $27.05 | +1.3% | 711.97K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NewAmsterdam Pharma Company N.V. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW